Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Psychiatry Reports
Erschienen in: Current Psychiatry Reports 4/2011

01.08.2011

Prevention of Anxiety Disorders

verfasst von: Elizabeth X. Lau, Ronald M. Rapee

Erschienen in: Current Psychiatry Reports | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Research into the prevention of anxiety has increased dramatically in the past few years. Prevention programs have been directed at broad, nonspecific anxiety and at more specific anxiety types, such as panic disorder and post-traumatic stress disorder. Prevention of anxiety is still a relatively new field, but there has been a recent surge of literature reporting on different prevention programs. Universal prevention trials have shown modest but promising results, and school-based programs offered to all students also help to reduce stigmatization and common barriers to accessing treatment (eg, time, location, and cost). In contrast, targeted programs tend to show somewhat larger effects but rely on identification of relevant populations. Specific programs for the prevention of panic disorder and post-traumatic stress disorder have also demonstrated some preliminary success. This paper reviews the recent studies of prevention of anxiety and discusses several key issues, specifically (1) identification of at-risk participants for prevention programs, (2) motivation for participation, (3) optimal age for intervention, and (4) who should deliver the program.
Literatur
1.
Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.PubMedCrossRef
2.
Olatunji BO, Cisler JM, Tolin DF. Quality of life in the anxiety disorders: a meta-analytic review. Clin Psychol Rev. 2007;27(5):572–81.PubMedCrossRef
3.
Bruce SE, Yonkers KA, Otto MW, et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry. 2005;162:1179–87.PubMedCrossRef
4.
Beesdo K, Bittner A, Pine DS, et al. Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Arch Gen Psychiatry. 2007;64:903–12.PubMedCrossRef
5.
Beesdo K, Pine DS, Lieb R, Wittchen HU. Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry. 2010;67:47–57.PubMedCrossRef
6.
Norton GR, McLeod L, Guertin J, et al. Panic disorder or social phobia: which is worse? Behav Res Ther. 1996;34(3):273–6.PubMedCrossRef
7.
Roy-Byrne PP, Katon W. Generalized anxiety disorder in primary care: the precursor/modifier pathway to increased health care utilization. J Clin Psychiatry. 1997;58:34–40.PubMedCrossRef
8.
Last CG, Hansen C, Franco N. Anxious children in adulthood: a prospective study of adjustment. J Am Acad Child Adolesc Psychiatry. 1997;36:645–52.PubMedCrossRef
9.
Weissman MM, Wolk S, Wickramaratne P, et al. Children with prepubertal-onset major depressive disorder and anxiety grown up. Arch Gen Psychiatry. 1999;56(9):794–801.PubMedCrossRef
10.
Greenberg PE, Sisitsky T, Kessler RC, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999;60:427–35.PubMedCrossRef
11.
Canino G, Shrout PE, Rubio-Stipec M, et al. The DSM-IV rates of child and adolescent disorders in Puerto Rico: prevalence, correlates, service use, and the effects of impairment. Arch Gen Psychiatry. 2004;61(1):85–93.PubMedCrossRef
12.
Issakidis C, Andrews G. Service utilisation for anxiety in an Australian community sample. Soc Psychiatry Psychiatr Epidemiol. 2002;37:153–63.PubMedCrossRef
13.
Cicchetti D, Toth SL. The development of depression in children and adolescents. Am Psychol. 1998;53:221–41.PubMedCrossRef
14.
Rapee RM, Spence SH. The etiology of social phobia: empirical evidence and an initial model. Clin Psychol Rev. 2004;24:737–67.PubMedCrossRef
15.
Rapee RM, Kennedy S, Ingram M, et al. Prevention and early intervention of anxiety disorders in inhibited preschool children. J Consult Clin Psychol. 2005;73:488–97.PubMedCrossRef
16.
Kennedy S, Rapee RM, Edwards S. A selective intervention program for inhibited preschool-aged children of parents with an anxiety disorder: effects on current anxiety disorders and temperament. J Am Acad Child Adolesc Psychiatry. 2009;48:602–9.PubMedCrossRef
17.
Andrews G, Issakidis C, Sanderson K, et al. Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry. 2004;184:526–33.PubMedCrossRef
18.
Feldner MT, Zvolensky MJ, Schmidt NB. Prevention of anxiety psychopathology: a critical review of the empirical literature. Clin Psychol Sci Pract. 2004;11:405–24.CrossRef
19.
Rapee RM. Prevention of mental disorders: promises, limitations, and barriers. Cogn Behav Pract. 2008;15:47–52.
20.
Mrazek PJ, Haggerty RJ. Reducing risks for mental disorders. Washington: National Academy Press; 1994.
21.
Gordon R. An operational classification of disease prevention. Public Health Rep. 1983;98:107–9.PubMed
22.
Offord DR, Chmura Kraemer H, Kazdin AE, et al. Lowering the burden of suffering from child psychiatric disorder: trade-offs among clinical, targeted, and universal interventions. J Am Acad Child Adolesc Psych. 1998;37:686–94.CrossRef
23.
Barrett P, Turner C. Prevention of anxiety symptoms in primary school children: preliminary results from a universal school-based trial. Br J Clin Psychol. 2001;40(4):399–410.PubMedCrossRef
24.
Lowry-Webster HM, Barrett P, Lock S. A universal prevention trial of anxiety symptomology during childhood: results at 1-year follow-up. Behav Change. 2003;20:25–43.CrossRef
25.
Lock S, Barrett P. A longitudinal study of developmental differences in universal preventive intervention for child anxiety. Behav Change. 2003;20:183–99.CrossRef
26.
Lowry-Webster HM, Barrett P, Dadds M. A universal prevention trial of anxiety and depressive symptomatology in childhood: preliminary data from an Australian study. Behav Change. 2001;18:36–50.CrossRef
27.
Farrell LJ, Barrett P. Prevention of childhood emotional disorders: reducing the burden of suffering associated with anxiety and depression. Child Adolesc Ment Health. 2007;12:58–65.CrossRef
28.
Kendall PC. Treating anxiety disorders in children: results of a randomized clinical trial. J Consult Clin Psychol. 1994;62(1):100–10.PubMedCrossRef
29.
Barrett PM, Locks S, Farrell LJ. Developmental differences in universal preventive intervention for child anxiety. Clin Child Psychol Psychiatry. 2005;10:539–55.CrossRef
30.
Miller LD. Facing fears: the feasibility of anxiety universal prevention efforts with children and adolescents. Cogn Behav Pract. 2008;15(1):28–35.
31.
Stallard P, Simpson N, Anderson S, et al. The FRIENDS emotional health programme: initial findings from a school-based project. Child Adolesc Ment Health. 2007;12(1):32–7.CrossRef
32.
Stallard P, Simpson N, Anderson S, Goddard M. The FRIENDS emotional health prevention programme: 12 month follow-up of a universal UK school based trial. Eur Child Adolesc Psychiatry. 2008;17(5):283–9.PubMedCrossRef
33.
Barrett PM, Farrell LJ, Ollendick TH, Dadds M. Long-term outcomes of an Australian universal prevention trial of anxiety and depression symptoms in children and youth: an evaluation of the FRIENDS program. J Clin Child Adolesc Psychol. 2006;35(3):403–11.PubMedCrossRef
34.
Lyneham HJ, Rapee RM. Prevention of child and adolescent anxiety disorders. In: Silverman W, Field A, editors. Anxiety disorders in children and adolescents: research, assessment, and intervention. 2nd ed. Cambridge University Press; 2011, in press.
35.
Dadds M, Roth J. Prevention of anxiety disorders: results of a universal trial with young children. J Child Fam Stud. 2008;17(3):320–35.CrossRef
36.
Aune T, Stiles TC. Universal-based prevention of syndromal and subsyndromal social anxiety: a randomized controlled study. J Consult Clin Psychol. 2009;77:867–79.PubMedCrossRef
37.
• Neil AL, Christensen H. Efficacy and effectiveness of school-based prevention and early intervention programs for anxiety. Clin Psychol Rev. 2009;29:208–15. This paper provides a systematic review of school-based anxiety prevention programs.PubMedCrossRef
38.
Rapee RM, Schniering CA, Hudson JL. Anxiety disorders during childhood and adolescence: origins and treatment. Annu Rev Clin Psychol. 2009;5:311–41.PubMedCrossRef
39.
Rapee RM, Kennedy S, Ingram M, et al. Altering the trajectory of anxiety in at-risk young children. Am J Psychiatry. 2010;167:1518–25.PubMedCrossRef
40.
Ginsburg GS. The Child Anxiety Prevention Study: intervention model and primary outcomes. J Consult Clin Psychol. 2009;77(3):580–7.PubMedCrossRef
41.
Balle M, Tortella-Feliu M. Efficacy of a brief school-based program for selective prevention of childhood anxiety. Anxiety Stress Coping. 2010;23:71–85.PubMedCrossRef
42.
Dadds MR, Holland DE, Laurens KR, et al. Early intervention and prevention of anxiety disorders in children: results at 2-year follow-up. J Consult Clin Psychol. 1999;67(1):145–50.PubMedCrossRef
43.
Dadds MR, Spence SH, Holland DE, et al. Prevention and early intervention for anxiety disorders: a controlled trial. J Consult Clin Psychol. 1997;65(4):627–35.PubMedCrossRef
44.
Bernstein GA, Bernat DH, Victor AM, Layne AE. School-based interventions for anxious children: 3-, 6-, and 12-month follow-ups. J Am Acad Child Adolesc Psychiatry. 2008;47(9):1039–47.PubMed
45.
Bernstein GA, Layne AE, Egan EA, Tennison DM. School-based interventions for anxious children. J Am Acad Child Adolesc Psychiatry. 2005;44(11):1118–27.PubMedCrossRef
46.
Hunt C, Andrews G, Crino R, et al. Randomized controlled trial of an early intervention programme for adolescent anxiety disorders. Aust N Z J Psychiatry. 2009;43:300–4.PubMedCrossRef
47.
Liddle I, Macmillan S. Evaluating the FRIENDS programme in a Scottish setting. Educ Psychol Pract. 2010;26:53–67.CrossRef
48.
Mifsud C, Rapee RM. Early intervention for childhood anxiety in a school setting: outcomes for an economically disadvantaged population. J Am Acad Child Adolesc Psychiatry. 2005;44:996–1004.PubMedCrossRef
49.
Craske MG, Barlow DH. Panic disorder and agoraphobia. In: Barlow DH, editor. Clinical handbook of psychological disorders: a step-by-step treatment manual. 3rd ed. New York: Guilford; 2001. p. 1–59.
50.
Ehlers A. A l-year prospective study of panic attacks: clinical course and factors associated with maintenance. J Abnorm Psychol. 1995;104:164–72.PubMedCrossRef
51.
Schmidt NB, Lerew DR, Jackson RJ. The role of anxiety sensitivity in the pathogenesis of panic: prospective evaluation of spontaneous panic attacks during acute stress. J Abnorm Psychol. 1997;106:355–64.PubMedCrossRef
52.
Schmidt NB, Lerew DR, Jackson RJ. Prospective evaluation of anxiety sensitivity in the pathogenesis of panic: replication and extension. J Abnorm Psychol. 1999;108:532–7.PubMedCrossRef
53.
Gardenswartz CA, Craske MG. Prevention of panic disorder. Behav Ther. 2001;32:725–37.CrossRef
54.
Resnick H, Acierno R, Holmes M, et al. Prevention of post-rape psychopathology: preliminary findings of a controlled acute rape treatment study. J Anxiety Disord. 1999;13:359–70.PubMedCrossRef
55.
La Greca AM, Silverman WS. Treatment and prevention of posttraumatic stress reactions in children and adolescents exposed to disasters and terrorism: what is the evidence? Child Dev Perspect. 2009;3:4–10.CrossRef
56.
Feldner MT, Monson CM, Friedman MJ. A critical analysis of approaches to targeted PTSD prevention: current status and theoretically derived future directions. Behav Modif. 2007;31:80–116.PubMedCrossRef
57.
Berger R, Pat-Horenczyk R, Gelkopf M. School-based intervention for prevention and treatment of elementary-students’ terror-related distress in Israel: a quasi-randomized controlled trial. J Trauma Stress. 2007;20(4):541–51.PubMedCrossRef
58.
Gelkopf M, Berger R. A school-based, teacher-mediated prevention program (ERASE-Stress) for reducing terror-related traumatic reactions in Israeli youth: a quasi-randomized controlled trial. J Child Psychol Psychiatry. 2009;50:962–71.PubMedCrossRef
59.
Schniering CA, Hudson JL, Rapee RM. Issues in the diagnosis and assessment of anxiety disorders in children and adolescents. Clin Psychol Rev. 2000;40:453–78.CrossRef
60.
Silverman WK, Ollendick TH. Evidence-based assessment of anxiety and its disorders in children and adolescents. J Clin Child Adolesc Psychol. 2005;34:380–411.PubMedCrossRef
61.
Ashford J, Smit F, Van Lier PAC, et al. Early risk indicators of internalizing problems in late childhood: a 9-year longitudinal study. J Child Psychol Psychiatry. 2008;49:774–80.PubMedCrossRef
62.
Dozois DJA. Prevention of anxiety psychopathology: conceptual, methodological, and practical issues. Clin Psychol Sci Pract. 2004;11:425–9.CrossRef
63.
Last CG, Perrin S, Hersen M, Kazdin AE. A prospective study of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry. 1996;35:1502–10.PubMedCrossRef
64.
Hirshfeld-Becker DR, Biederman J. Rationale and principles for early intervention with young children at risk for anxiety disorders. Clin Child Fam Psychol Rev. 2002;5(3):161–72.PubMedCrossRef
65.
Calear AL, Christensen H, Mackinnon A, et al. The YouthMood Project: a cluster randomized controlled trial of an online cognitive behavioral program with adolescents. J Consult Clin Psychol. 2009;77:1021–32.PubMedCrossRef
66.
Masia-Warner C, Nangle DW, Hansen DJ. Bringing evidence-based child mental health services to the schools: general issues and specific populations. Educ Treat Child. 2006;29:165–72.
67.
McLoone J, Hudson JL, Rapee RM. Treating anxiety disorders in a school setting. Educ Treat Child. 2006;29:219–42.
68.
Andrews G, Szabo M, Burns J. Preventing major depression in young people. Br J Psychiatry. 2002;181:460–2.PubMedCrossRef
Metadaten
Titel
Prevention of Anxiety Disorders
verfasst von
Elizabeth X. Lau
Ronald M. Rapee
Publikationsdatum
01.08.2011
Verlag
Current Science Inc.
Erschienen in
Current Psychiatry Reports / Ausgabe 4/2011
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-011-0199-x

Weitere Artikel der Ausgabe 4/2011

Current Psychiatry Reports 4/2011 Zur Ausgabe

ReviewPaper

Perceived Ugliness: An Update on Treatment-Relevant Aspects of Body Dysmorphic Disorder

ReviewPaper

Update: Schizophrenia Across Cultures

CLINICAL TRIAL REPORT

What Can We Expect From Long-Acting Formulations for Schizophrenia?

ReviewPaper

Motor Symptoms of Schizophrenia: Is Tardive Dyskinesia a Symptom or Side Effect? A Modern Treatment

ReviewPaper

Late-life Anxiety Disorders: A Review

ReviewPaper

Selective Mutism: An Update and Suggestions for Future Research

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise